
Enimmune corporation 6564.TWO
6564.TWO
Enimmune corporation 6872.TWO
NaviFUS Corp. 6810.TWO
Bio Preventive Medicine Corp. 7427.TWO
Great Novel Therapeutics Biotech & Medicals 6850.TWO
BiOptic Inc. 4133.TW
Abnova (Taiwan) Corporation 6876.TWO
LAUNXP Biomedical Co., Ltd 4194.TWO
Holy Stone Healthcare Co., Ltd. 7725.TWO
LabTurbo Biotech Corporation 4195.TWO
Genomics BioSci & Tech. Co.,Ltd.
Enimmune corporation 6872.TWO
NaviFUS Corp. 6810.TWO
Bio Preventive Medicine Corp. 7427.TWO
Great Novel Therapeutics Biotech & Medicals 6850.TWO
BiOptic Inc. 4133.TW
Abnova (Taiwan) Corporation 6876.TWO
LAUNXP Biomedical Co., Ltd 4194.TWO
Holy Stone Healthcare Co., Ltd. 7725.TWO
LabTurbo Biotech Corporation 4195.TWO
Genomics BioSci & Tech. Co.,Ltd.
Performance
Periode | 6564.TWO | 6872.TWO | 6810.TWO | 7427.TWO | 6850.TWO | 4133.TW | 6876.TWO | 4194.TWO | 7725.TWO | 4195.TWO |
---|---|---|---|---|---|---|---|---|---|---|
6M | 11.78 % | -20.59 % | 4.26 % | -10.34 % | 11.44 % | 1.18 % | 42.27 % | 29.67 % | 1.25 % | 38.95 % |
YTD | -14.08 % | -27.16 % | -18.50 % | -1.46 % | 16.61 % | -11.70 % | 22.61 % | -20.73 % | -7.07 % | 30.99 % |
1Y | -34.21 % | -30.17 % | -21.26 % | -5.19 % | 1.52 % | -14.36 % | 41.86 % | -40.30 % | -10.66 % | 42.09 % |
3Y | -56.25 % | -6.08 % | -30.18 % | 4.77 % | 53.77 % | -23.20 % | 8.93 % | -48.04 % | -39.10 % | 35.58 % |
5Y | -53.05 % | -16.77 % | 18.06 % | -40.51 % | 15.22 % | -63.82 % | 8.93 % | -26.17 % | -39.10 % | 44.13 % |
10Y | -33.98 % | -16.77 % | 18.06 % | -40.51 % | 15.22 % | -14.10 % | 8.93 % | -67.40 % | -39.10 % | 36.76 % |
From the beginning | -33.98 % | -16.77 % | 18.06 % | -40.51 % | 15.22 % | -76.93 % | 8.93 % | -90.45 % | -39.10 % | -16.53 % |